Mitochondria and Mitochondrial Cascades in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
Decades of research indicate mitochondria from Alzheimer’s disease (AD) patients differ from those of non-AD individuals. Initial studies revealed structural differences, and subsequent studies showed functional deficits. Observations of structure and function changes prompted investigators to consider the consequences, significance, and causes of AD-related mitochondrial dysfunction. Currently, extensive research argues mitochondria may mediate, drive, or contribute to a variety of AD pathologies. The perceived significance of these mitochondrial changes continues to grow, and many currently believe AD mitochondrial dysfunction represents a reasonable therapeutic target. Debate continues over the origin of AD mitochondrial changes. Some argue amyloid-β (Aβ) induces AD mitochondrial dysfunction, a view that does not challenge the amyloid cascade hypothesis and that may in fact help explain that hypothesis. Alternatively, data indicate mitochondrial dysfunction exists independent of Aβ, potentially lies upstream of Aβ deposition, and suggest a primary mitochondrial cascade hypothesis that assumes mitochondrial pathology hierarchically supersedes Aβ pathology. Mitochondria, therefore, appear at least to mediate or possibly even initiate pathologic molecular cascades in AD. This review considers studies and data that inform this area of AD research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mitochondria, too, are damaged by oxidative and nitrosative stress in AD as noted [34].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of Aβ oligomers in mitochondrial membranes is consistent with Aβ-induced mitochondrial dysfunction occurring early in the disease progression timeline [34,53].”
From Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease (2020) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mitochondrial dysfunction plays a fundamental role in AD pathogenesis2 and represents an early event2.”
From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mitochondrial dysfunction plays a fundamental role in AD pathogenesis2 and represents an early event2.”
From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Oxidative stress from mitochondrial dysfunction and reactive oxygen species (ROS) accumulation further heightens neuronal vulnerability [6].”
From What Are the Key Biological Pathways Through Which Lifestyle Factors Influence Neurodegeneration? (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Davis, R. E., Miller, S., Herrnstadt, C., Ghosh, S. S., Fahy, E., Shinobu, L. A., Galasko, D., Thal, L. J., Beal, M. F., Howell, N., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4526 · Cited by 341
RetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“Based on assumptions made by the amyloid cascade hypothesis, first proposed in the early 1990 s [22, 23], the latter possibility seemed more likely.”
BackgroundSperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · cited 1×
“plaques may arguably have AD; a current construct refers to this state as “preclinical AD” [144].”
BackgroundHypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734 · cited 1×
“Due to the presence of the mutated mtPOLG transgene, these mice acquire excess somatic mtDNA mutations and mitochondrial dysfunction [65, 66].”
BackgroundAmyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“Based on assumptions made by the amyloid cascade hypothesis, first proposed in the early 1990 s [22, 23], the latter possibility seemed more likely.”
BackgroundBloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194 · cited 1×
“In response to this, some now speculate A itself is insufficient to cause the disease, but instead initiates AD by triggering a critical change in tau biology [114, 119, 120].”
BackgroundMitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · cited 1×
“A popular line of AD research argues A , and perhaps specifically oligomeric conformations of a 42 amino acid-long A species, initiates neurodegeneration [24, 25].”
BackgroundPrevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 2×
“Later studies confirmed and extended the finding [3, 4].”
ResultReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Mitochondrial Genetics: A Paradigm for Aging and Degenerative Diseases?
Wallace, D. C. (1992) · Science · doi:10.1126/science.1533953 · Cited by 1,262
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1357-09.2009 · Cited by 1,224
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
ATP as a biological hydrotrope
Patel, A., Malinovska, L., Saha, S., Wang, J., Alberti, S., Krishnan, Y., & Hyman, A. A. (2017) · Science · doi:10.1126/science.aaf6846 · Cited by 1,019 · cited 1×
“showed that ATP functions as a “hydrotrope” [106, 107].”
BackgroundCalcium dyshomeostasis and intracellular signalling in alzheimer's disease
LaFerla, F. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn960 · Cited by 978
Du, H., Guo, L., Fang, F., Chen, D., A Sosunov, A., M McKhann, G., Yan, Y., Wang, C., Zhang, H., Molkentin, J. D., et al. (2008) · Nature Medicine · doi:10.1038/nm.1868 · Cited by 932 · cited 1×
“CypD knock-out reduced oxidative stress and apoptosis, and cypD knock-out preserved cognitive performance in A PP transgenic mice [36].”
BackgroundWang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835
Manczak, M., Calkins, M. J., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr139 · Cited by 827
Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786
Self-citationA “mitochondrial cascade hypothesis” for sporadic Alzheimer’s disease
Swerdlow, R. H., & Khan, S. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.045 · Cited by 758
Self-citationMitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease
Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738
Snowdon, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530310034029 · Cited by 696
Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806192105 · Cited by 693 · cited 1×
“However, analyses show mitochondria from AD subject autopsy brains do appear to contain A [33, 35, 38, 39].”
BackgroundFRACKOWIAK, R. S. J., POZZILLI, C., LEGG, N. J., BOULAY, G. H., MARSHALL, J., LENZI, G. L., & JONES, T. (1981) · Brain · doi:10.1093/brain/104.4.753 · Cited by 683
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Musiek, E. S., & Holtzman, D. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4018 · Cited by 662 · cited 1×
“In response to this, some now speculate A itself is insufficient to cause the disease, but instead initiates AD by triggering a critical change in tau biology [114, 119, 120].”
BackgroundSmall, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Cytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598 · cited 2×
“cytochrome oxidase (COX) activity [21].”
BackgroundAnandatheerthavarada, H. K., Biswas, G., Robin, M.-A., & Avadhani, N. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207030 · Cited by 571 · cited 1×
“cytosol) reportedly reduces COX activity [40].”
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562
Self-citationReiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A. M., Shah, A. R., Alvarez, S., Arbelaez, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70228-4 · Cited by 541
Alzheimer's disease: Focal cortical changes shown by positron emission tomography
Foster, N. L., Chase, T. N., Fedio, P., Patronas, N. J., Brooks, R. A., & Chiro, G. D. (1983) · Neurology · doi:10.1212/wnl.33.8.961 · Cited by 540
β‐Amyloid inhibits integrated mitochondrial respiration and key enzyme activities
Casley, C. S., Canevari, L., Land, J. M., Clark, J. B., & Sharpe, M. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00681.x · Cited by 480
Cytosolic proteostasis through importing of misfolded proteins into mitochondria
Ruan, L., Zhou, C., Jin, E., Kucharavy, A., Zhang, Y., Wen, Z., Florens, L., & Li, R. (2017) · Nature · doi:10.1038/nature21695 · Cited by 474
Friedland, R. P., Budinger, T. F., Ganz, E., Yano, Y., Mathis, C. A., Koss, B., Ober, B. A., Huesman, R. H., & Derenzo, S. E. (1983) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198308000-00003 · Cited by 468
Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease
Joachim, C. L., Mori, H., & Selkoe, D. J. (1989) · Nature · doi:10.1038/341226a0 · Cited by 462
Gibson, G. E., Sheu, K.-F. R., Blass, J. P., Baker, A., Carlson, K. C., Harding, B., & Perrino, P. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320022009 · Cited by 424 · cited 2×
“Blass, Gibson, and colleagues first showed reduced KGDHC activity in fibroblasts, and lowered transketolase activity in red blood cells [16].”
BackgroundBrain β-amyloid load approaches a plateau
Jack, C. R., Wiste, H. J., Lesnick, T. G., Weigand, S. D., Knopman, D. S., Vemuri, P., Pankratz, V. S., Senjem, M. L., Gunter, J. L., Mielke, M. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840bbe · Cited by 406
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404
Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
Sorbi, S., Bird, E. D., & Blass, J. P. (1983) · Annals of Neurology · doi:10.1002/ana.410130116 · Cited by 396 · cited 2×
“Blass, Gibson, and colleagues first showed reduced KGDHC activity in fibroblasts, and lowered transketolase activity in red blood cells [16].”
BackgroundGabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., & Yankner, B. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36875-8 · Cited by 373 · cited 1×
“found COX inhibition shifts A PP processing toward the amyloidogenic pathway that ultimately produces A [60].”
BackgroundMitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation
Leuner, K., Schütt, T., Kurz, C., Eckert, S. H., Schiller, C., Occhipinti, A., Mai, S., Jendrach, M., Eckert, G. P., Kruse, S. E., et al. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4173 · Cited by 354 · cited 1×
“Mitochondria-generated reactive oxygen species may play a particularly important role in shifting A PP processing to A [61].”
BackgroundWang, X., Su, B., Fujioka, H., & Zhu, X. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071208 · Cited by 341
Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42
Crouch, P. J., Blake, R., Duce, J. A., Ciccotosto, G. D., Li, Q.-X., Barnham, K. J., Curtain, C. C., Cherny, R. A., Cappai, R., Dyrks, T., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4276-04.2005 · Cited by 327
Reddy, P. H., McWeeney, S., Park, B. S., Manczak, M., Gutala, R. V., Partovi, D., Jung, Y., Yau, V., Searles, R., Mori, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh140 · Cited by 326 · cited 1×
“found that in mice expressing a mutant human A PP transgene, an apparent compensatory upregulation of respiratory chain enzyme subunits preceded both behavioral change and A plaque deposition [48].”
BackgroundMitochondrial permeability transition pore is a potential drug target for neurodegeneration
Rao, V. K., Carlson, E. A., & Yan, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.003 · Cited by 324
The dysregulation of intracellular calcium in Alzheimer disease
Supnet, C., & Bezprozvanny, I. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.014 · Cited by 323 · cited 1×
“some propose an AD “calcium hypothesis [47].”
Chang, S., Ma, T. R., Miranda, R. D., Balestra, M. E., Mahley, R. W., & Huang, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508254102 · Cited by 319
Mitochondrial alterations in Alzheimer's disease
Baloyannis, S. J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9204 · Cited by 318 · cited 1×
“Later studies confirmed and extended the finding [3, 4].”
ResultAmyloid‐Beta Interaction with Mitochondria
Pagani, L., & Eckert, A. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/925050 · Cited by 309 · cited 2×
“If A causes these mitochondrial perturbations in autopsy brains, and these mitochondrial perturbations in turn contribute to neuron dysfunction or degeneration, they could represent evidence of an A -induced, mitochondria-mediated cascade [43, 53].”
BackgroundAbnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines
Trimmer, P. A., Swerdlow, R. H., Parks, J. K., Keeney, P., Bennett, J. P., Miller, S. W., Davis, R. E., & Parker, W. D. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7333 · Cited by 296
Self-citationCybrids in Alzheimer's disease: a cellular model of the disease?
Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Maguire, D. J., Maguire, R. S., Bennett, J. P., Davis, R. E., & Parker, W. D. (1997) · Neurology · doi:10.1212/wnl.49.4.918 · Cited by 272
Self-citationMitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity
Cardoso, S. M., Santana, I., Swerdlow, R. H., & Oliveira, C. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02438.x · Cited by 261
Self-citationCybrids in Alzheimer's disease: A cellular model of the disease?
Swerdlow, R. H., & Parker, D. W. (1998) · Neurology · doi:10.1212/wnl.51.1.326-a · Cited by 260
Self-citationGibson, G. E., Starkov, A., Blass, J. P., Ratan, R. R., & Beal, M. F. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.08.010 · Cited by 256 · cited 1×
“Functional differences from control subjects were later demonstrated in additional Krebs cycle enzymes [17].”
BackgroundSheehan, J. P., Swerdlow, R. H., Miller, S. W., Davis, R. E., Parks, J. K., Parker, W. D., & Tuttle, J. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04612.1997 · Cited by 249 · cited 2×
“Similarly, a secondary mitochondrial cascade would infer that outside the brain, brain-derived A causes changes to mitochondrial function [80] and calcium homeostasis [141–143], while a primary mitochondrial cascade would infer those changes arise independent of A , and perhaps drive local A deposition [70, 72].”
BackgroundSelf-citationAbnormal Mitochondrial Dynamics in the Pathogenesis of Alzheimer's Disease
Zhu, X., Perry, G., Smith, M. A., & Wang, X. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129005 · Cited by 242 · cited 1×
“If A causes these mitochondrial perturbations in autopsy brains, and these mitochondrial perturbations in turn contribute to neuron dysfunction or degeneration, they could represent evidence of an A -induced, mitochondria-mediated cascade [43, 53].”
BackgroundWISNIEWSKI, H., TEKRY, R. D., & HIHANO, A. (1970) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-197004000-00001 · Cited by 242 · cited 1×
“Over 40 years ago, electron microscopy (EM) pictures of Alzheimer’s disease (AD) brains revealed altered mitochondrial infrastructures [1, 2].”
BackgroundMaternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism
Mosconi, L., Brys, M., Switalski, R., Mistur, R., Glodzik, L., Pirraglia, E., Tsui, W., De Santi, S., & de Leon, M. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705036104 · Cited by 237
Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yonekura, Y., & Konishi, J. (1994) · PubMed · Cited by 228
Chen, H.-K., Ji, Z.-S., Dodson, S. E., Miranda, R. D., Rosenblum, C. I., Reynolds, I. J., Freedman, S. B., Weisgraber, K. H., Huang, Y., & Mahley, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151084 · Cited by 209
Mitochondrial alterations Alzheimer's disease
Baloyannis, S. J., Costa, V., & Michmizos, D. (2004) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/153331750401900205 · Cited by 206
The Alzheimer's disease mitochondrial cascade hypothesis: an update
Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206
Self-citationFunctional mitochondria are required for amyloid β‐mediated neurotoxicity
Cardoso, S. M., Santos, S., Swerdlow, R. H., & Oliveira, C. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0561fje · Cited by 203
Self-citationSwerdlow, R. H. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4149 · Cited by 203 · cited 2×
“The magnitude of the difference between COX activity means varies between studies, but generally reflects a 15–40% activity reduction [80].”
BackgroundSelf-citationParks, J. K., Smith, T. S., Trimmer, P. A., Bennett, J. P., & Parker, W. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00112.x · Cited by 199
Positron Emission Tomography in the Study of Aging and Senile Dementia
Ferris, S. H., de Leon, M. J., Wolf, A. P., Farkas, T., Christman, D. R., Reisberg, B., Fowler, J. S., MacGregor, R., Goldman, A., George, A. E., et al. (1980) · Neurobiology of Aging · doi:10.1016/0197-4580(80)90005-6 · Cited by 198
KHACHATURIAN, Z. S. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb12485.x · Cited by 198
β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria
Canevari, L., Clark, J. B., & Bates, T. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01028-5 · Cited by 196
Positron emission tomographic studies of aging and Alzheimer disease.
de Leon, M. J., Ferris, S. H., GEORGE, A. E., Christman, D. R., Fowler, J. S., Gentes, C., Reisberg, ., Gee, B., Emmerich, M., Yonekura, Y., et al. (1983) · PubMed Central · Cited by 187
Fukui, H., Diaz, F., Garcia, S., & Moraes, C. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705738104 · Cited by 185 · cited 1×
“Moraes and colleagues previously reported, in two studies using different approaches, that interfering with respiratory chain assembly actually reduces A plaque deposition [67, 68].”
ResultYao, J., Du, H., Yan, S., Fang, F., Wang, C., Lue, L.-F., Guo, L., Chen, D., Stern, D. M., Gunn Moore, F. J., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4717-10.2011 · Cited by 184
Brain injury biomarkers are not dependent on β‐amyloid in normal elderly
Knopman, D. S., Jack, C. R., Wiste, H. J., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23816 · Cited by 183 · cited 1×
“Further, those with AD phenotypes that lack amyloid plaques and an obvious alternative clinical diagnosis arguably do not have AD; a current construct refers to this state as “suspected non-Alzheimer pathology” (SNAP) [145].”
BackgroundMitochondrial function in brain tissue in primary degenerative dementia
Sims, N. R., Finegan, J. M., Blass, J. P., Bowen, D. M., & Neary, D. (1987) · Brain Research · doi:10.1016/0006-8993(87)91553-8 · Cited by 182
Gan, X., Huang, S., Wu, L., Wang, Y., Hu, G., Li, G., Zhang, H., Yu, H., Swerdlow, R. H., Chen, J. X., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.009 · Cited by 180
Self-citationAlzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.
Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Pa, T., Krebs, C. T., Bennett, J. C., Parks, J. K., Swerdlow, R. H., et al. (2000) · PubMed · Cited by 176
Self-citationDeregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease
Beck, S. J., Guo, L., Phensy, A., Tian, J., Wang, L., Tandon, N., Gauba, E., Lu, L., Pascual, J. M., Kroener, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11483 · Cited by 174 · cited 1×
“However, analyses show mitochondria from AD subject autopsy brains do appear to contain A [33, 35, 38, 39].”
BackgroundIs aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow, R. H. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.021 · Cited by 172 · cited 1×
“Also, as mitochondrial function generally declines during aging [102], it tries to bridge AD and aging research by providing a platform that potentially explains why advancing age represents the single greatest AD risk factor [103].”
BackgroundSelf-citationNeuronal Calcium Signaling, Mitochondrial Dysfunction, and Alzheimer's Disease
Supnet, C., & Bezprozvanny, I. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100306 · Cited by 160
Askanas, V., Engel, W. K., & Alvarez, R. B. (1992) · PubMed · Cited by 159
Altered Calcium Uptake in Cultured Skin Fibroblasts from Patients with Alzheimer's Disease
Peterson, C. M., Gibson, G. E., & Blass, J. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504183121618 · Cited by 157
Reddy, P. H. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132060 · Cited by 151 · cited 1×
“fission represents one such approach [147].”
Valla, J., Yaari, R., Wolf, A. B., Kusne, Y., Beach, T. G., Roher, A. E., Corneveaux, J. J., Huentelman, M. J., Caselli, R. J., & Reiman, E. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100129 · Cited by 150 · cited 1×
“Results from at least one direct biochemical study of brain tissue are consistent with these findings from living subjects [139].”
ResultNeurochemical enzyme changes in Alzheimer's and Pick's disease
Meier‐Ruge, W., Iwangoff, P., & Reichlmeier, K. (1984) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(84)90007-4 · Cited by 146 · cited 1×
“Some studies noted reductions in glycolysis enzymes [14].”
BackgroundAlzheimer disease and platelets: how’s that relevant
Catricalà, S., Torti, M., & Ricevuti, G. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-20 · Cited by 142
Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease.
Fernández‐Vizarra, P., Fernández, A. P., Castro‐Blanco, S., Serrano, J., Bentura, M. L., Martínez‐Murillo, R., Martínez, A., & Rodrigo, J. (2004) · PubMed · doi:10.14670/hh-19.823 · Cited by 141 · cited 1×
“However, analyses show mitochondria from AD subject autopsy brains do appear to contain A [33, 35, 38, 39].”
BackgroundMiller, S. W., Trimmer, P. A., Parker, W. D., & Davis, R. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051897.x · Cited by 140
Mosconi, L., Rinne, J. O., Tsui, W. H., Berti, V., Li, Y., Wang, H., Murray, J., Scheinin, N., Någren, K., Williams, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914141107 · Cited by 135
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Roy, N., Hutfles, L., Burns, J. M., Michaelis, E. K., Yan, S., Cardoso, S. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt247 · Cited by 133
Self-citationMitochondria in cybrids containing mtDNA from persons with mitochondriopathies
Swerdlow, R. H. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21167 · Cited by 128 · cited 1×
“Because the nuclear component of cybrid cell lines prepared using a particular 0 cell line is similar if not identical, different cybrid cell lines generally contain the same nuclear DNA [76].”
BackgroundSelf-citationAltered metabolic properties of cultured skin fibroblasts in Alzheimer's disease
Sims, N. R., Finegan, J. M., & Blass, J. P. (1987) · Annals of Neurology · doi:10.1002/ana.410210507 · Cited by 123 · cited 1×
“Reports from the mid-1980 s noted altered patterns of glucose and oxygen consumption in fibroblasts from AD subjects [54, 55].”
BackgroundWorker functions and traits associated with occupations and the development of AD
Smyth, K. A., Fritsch, T., Cook, T. B., McClendon, M. J., Santillan, C. E., & Friedland, R. P. (2004) · Neurology · doi:10.1212/01.wnl.0000133007.87028.09 · Cited by 119
An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease
Roses, A. D. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.88 · Cited by 118
Mitochondrial function impairment induced by amyloid β-peptide on PC12 cells
Pereira, C., Santos, M. S., & Oliveira, C. (1998) · NeuroReport · doi:10.1097/00001756-199806010-00015 · Cited by 115
Alzheimer’s disease: A metabolic systems degeneration?
Blass, J. P., & Zemcov, A. (1984) · Neurochemical Pathology · doi:10.1007/bf02834249 · Cited by 114 · cited 1×
“Proposed hypotheses included impaired blood-brain barrier glucose transport [13], reduced tissue energy requirements due to reduced synaptic activity, a tissue-loss artifact, and lesions of energy metabolism enzymes [10].”
BackgroundAβ-amyloid and Tau Imaging in Dementia
Villemagne, V. L., Doré, V., Bourgeat, P., Burnham, S. C., Laws, S., Salvado, O., Masters, C. L., & Rowe, C. C. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.006 · Cited by 110
Okonkwo, O. C., Xu, G., Oh, J. M., Dowling, N. M., Carlsson, C. M., Gallagher, C. L., Birdsill, A. C., Palotti, M. L., Wharton, W., Hermann, B. P., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs381 · Cited by 109
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease
Honea, R. A., Swerdlow, R. H., Vidoni, E. D., Goodwin, J., & Burns, J. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c918cb · Cited by 106
Self-citationMitochondria, Cybrids, Aging, and Alzheimer's Disease
Swerdlow, R. H., Koppel, S., Weidling, I., Hayley, C., Ji, Y., & Wilkins, H. M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2016.12.017 · Cited by 106 · cited 1×
“Also, as mitochondrial function generally declines during aging [102], it tries to bridge AD and aging research by providing a platform that potentially explains why advancing age represents the single greatest AD risk factor [103].”
BackgroundSelf-citationCybrids in Alzheimer's disease: A cellular model of the disease?
Schon, E. A., Shoubridge, E. A., & Moraes, C. T. (1998) · Neurology · doi:10.1212/wnl.51.1.326 · Cited by 101 · cited 1×
“AD cybrid cell lines were first created in the 1990 s to address the specific question of whether mtDNA contributes to lower platelet COX activity in AD subjects [72, 73].”
BackgroundProgressive regional atrophy in normal adults with a maternal history of Alzheimer disease
Honea, R. A., Swerdlow, R. H., Vidoni, E. D., & Burns, J. M. (2011) · Neurology · doi:10.1212/wnl.0b013e31820e7b74 · Cited by 99
Self-citationCassarino, D. S., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8866 · Cited by 98
Self-citationMosconi, L., de Leon, M., Murray, J., E, L., Lu, J., Javier, E., McHugh, P., & Swerdlow, R. H. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110866 · Cited by 97
Self-citationAmyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease
Anandatheerthavarada, H. K., & Devi, L. (2007) · The Neuroscientist · doi:10.1177/1073858407303536 · Cited by 95
Ghosh, S. S., Swerdlow, R. H., Miller, S. W., Sheeman, B., Parker, W. D., & DAVIS, R. E. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07825.x · Cited by 93
Self-citationTrimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., Parks, J. K., Parker, W. D., & Bennett, J. P. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.011 · Cited by 92
Self-citationKukreja, L., Kujoth, G. C., Prolla, T. A., LEUVEN, F. V., & Vassar, R. J. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-16 · Cited by 92 · cited 1×
“One study found transgenic mice that concurrently expressed a mutant human A PP gene and proof reading-defective mtDNA polymerase (mtPOLG) showed enhanced A plaque deposition [64].”
BackgroundZhang, H., Liu, Y., Lao, M., Ma, Z., & Yi, X. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.09.013 · Cited by 90
Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells
Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, M., & Govoni, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00536-3 · Cited by 89 · cited 1×
“Other cell culture studies suggest interfering with cell bioenergetics shifts A PP processing away from its non-amyloidogenic pathway, and presumably towards the amyloidogenic pathway [62, 63].”
BackgroundTrimmer, P. A., & Borland, M. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1101 · Cited by 88
Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions
Costa, R. O., Ferreiro, E. B., Martins, I., Santana, I. J., Cardoso, S. M., Oliveira, C. R., & Pereira, C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.011 · Cited by 87
Rice, A. M., & Rosen, M. K. (2017) · Science · doi:10.1126/science.aan4223 · Cited by 86 · cited 1×
“showed that ATP functions as a “hydrotrope” [106, 107].”
BackgroundAssociation of parental dementia with cognitive and brain MRI measures in middle-aged adults
Debette, S., Wolf, P. A., Beiser, A., Au, R., Himali, J. J., Pikula, A., Auerbach, S. H., DeCarli, C. S., & Seshadri, S. S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c67833 · Cited by 83 · cited 1×
“Middle-aged children of AD mothers who also carry an APOE4 allele perform relatively less well on memory testing [133].”
BackgroundMaternal family history is associated with Alzheimer's disease biomarkers
Honea, R. A., Initiative, F. T. A. D. N., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120676 · Cited by 79
Self-citationMitochondrial DNA polymorphisms specifically modify cerebral β-amyloid proteostasis
Scheffler, K., Krohn, M., Dunkelmann, T., Stenzel, J., Miroux, B., Ibrahim, S. M., Halbach, O. V. B. U., Heinze, H., Walker, L. C., Gsponer, J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0980-x · Cited by 65
Altered Glucose Metabolism in Fibroblasts from Patients with Alzheimer's Disease
Sims, N. R., Finegan, J. M., & Blass, J. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509053131013 · Cited by 64 · cited 1×
“Reports from the mid-1980 s noted altered patterns of glucose and oxygen consumption in fibroblasts from AD subjects [54, 55].”
BackgroundJohnson, T., & Blum, N. R. (1970) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197007000-00009 · Cited by 64 · cited 1×
“Over 40 years ago, electron microscopy (EM) pictures of Alzheimer’s disease (AD) brains revealed altered mitochondrial infrastructures [1, 2].”
BackgroundGan, X., Wu, L., Huang, S., Zhong, C., Shi, H., Li, G., Yu, H., Swerdlow, R. H., Chen, J. X., & Yan, S. S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.021 · Cited by 63
Self-citationWebster, M.-T., Pearce, B. R., Bowen, D. M., & Francis, P. T. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050098 · Cited by 62 · cited 1×
“Other cell culture studies suggest interfering with cell bioenergetics shifts A PP processing away from its non-amyloidogenic pathway, and presumably towards the amyloidogenic pathway [62, 63].”
BackgroundWilkins, H., Koppel, S. J., Bothwell, R. J., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.010 · Cited by 62
Self-citationStructural brain changes in normal individuals with a maternal history of Alzheimer's
Berti, V., Mosconi, L., Glodzik, L., Li, Y., Murray, J., De Santi, S., Pupi, A., Tsui, W., & De Leon, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.001 · Cited by 58
Onyango, I. G., Bennett, J. P., & Tuttle, J. B. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.026 · Cited by 56
Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets
Smith, C. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00738-6 · Cited by 56
Onyango, I. G., Tuttle, J. B., & Bennett, J. P. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.012 · Cited by 56
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy
Andrawis, J. P., Hwang, K. S., Green, A. E., Kotlerman, J., Elashoff, D., Morra, J. H., Cummings, J. L., Toga, A. W., Thompson, P. M., & Apostolova, L. G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.07.020 · Cited by 54
Starkov, A. A., & Beal, F. M. (2008) · Nature Medicine · doi:10.1038/nm1008-1020 · Cited by 53
Swerdlow, R. H. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12394 · Cited by 52 · cited 1×
“Pharmacologic manipulations that enhance aerobic or other aspects of mitochondrial function, or overall cell bioenergetics, could prove beneficial [148].”
BackgroundSelf-citationBrain Glucose Metabolism in Alzheimer’s Disease
Swerdlow, R. H., Marcus, D. L., Landman, J., Kooby, D. A., Frey, W. H., & Freedman, M. L. (1994) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199409000-00003 · Cited by 50
Self-citationHoyer, S. (1993) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099300600101 · Cited by 50
Pinto, M., Pickrell, A. M., Fukui, H., & Moraes, C. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.014 · Cited by 47 · cited 1×
“Moraes and colleagues previously reported, in two studies using different approaches, that interfering with respiratory chain assembly actually reduces A plaque deposition [67, 68].”
ResultMosconi, L., Glodzik, L., Mistur, R., McHugh, P., Rich, K. E., Javier, E., Williams, S., Pirraglia, E., De Santi, S., Mehta, P. D., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.011 · Cited by 46
Chen, G., Initiative, A. D. N., Shu, H., Chen, G., Ward, B. D., Antuono, P., Zhang, Z., & Li, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160537 · Cited by 42 · cited 1×
“Some studies, though, suggest when it comes to predicting or at least monitoring AD risk, particular AD-relevant biomarkers potentially predate low A CSF levels or A plaque deposits [121].”
BackgroundYu, Q., Du, F., Swerdlow, R. H., Yu, H., Chen, J. X., & Yan, S. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160532 · Cited by 42
Self-citationBioenergetics and metabolism: a bench to bedside perspective
Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 39 · cited 1×
“Proposed interventions include the use of molecules that can enhance bioenergetic fluxes or increase mitochondrial mass [149].”
BackgroundSelf-citationDecreased Brain Glucose Metabolism in Microvessels from Patients with Alzheimer's Diseasea
Marcus, D. L., & Freedman, M. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48476.x · Cited by 36 · cited 1×
“Proposed hypotheses included impaired blood-brain barrier glucose transport [13], reduced tissue energy requirements due to reduced synaptic activity, a tissue-loss artifact, and lesions of energy metabolism enzymes [10].”
BackgroundBijur, G. N., Davis, R. E., & Jope, R. S. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00168-0 · Cited by 36
Thiffault, C., & Bennett, J. P. (2005) · Mitochondrion · doi:10.1016/j.mito.2004.12.002 · Cited by 34
Jeong, J., Yum, K. S., Chang, J. Y., Kim, M., Ahn, J. Y., Kim, S., Lapchak, P. A., & Han, M. (2015) · BMC Neurology · doi:10.1186/s12883-015-0390-5 · Cited by 33
Prodromal Metabolic Phenotype in MCI Cybrids: Implications for Alzheimer’s Disease
F. Silva, D., Santana, I., R. Esteves, A., Baldeiras, I., M. Arduino, D., R. Oliveira, C., & M. Cardoso, S. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310020008 · Cited by 33
Wang, Y., Wu, F., Pan, H., Zheng, W., Feng, C. T., Wang, Y., Deng, Z., Wang, L., Luo, J., & Chen, S. (2016) · Scientific Reports · doi:10.1038/srep22244 · Cited by 30
Onyango, I. G., Ahn, J., Tuttle, J. B., Bennett Jr, J. P., & Swerdlow, R. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06871.x · Cited by 25 · cited 1×
“(cybrid) cell lines, in which the investigators generated human cell lines containing mtDNA from different individuals [70, 71].”
BackgroundSelf-citationReiter, K. E., Alpert, K. I., Cobia, D. J., Kwasny, M., Morris, J. C., Csernansky, J. G., & Wang, L. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.03.083 · Cited by 21
Molecular characterization of mtDNA depleted and repleted NT2 cell lines
Binder, D. R., Dunn, W. H., & Swerdlow, R. H. (2005) · Mitochondrion · doi:10.1016/j.mito.2005.04.003 · Cited by 20
Self-citationSarno, P. D., Bijur, G. N., Lü, R., Davis, R. E., & Jope, R. S. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00095-6 · Cited by 18
Liu, Z., Chen, H., Li, T., Xu, L., & Du, H. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12028 · Cited by 17
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Self-citation
Research works printed but not linked: 7
- de Leon MJ, 1983, AJNR Am J Neuroradiol, 4, 568
- Fukuyama H, 1994, J Nucl Med, 35, 1
- Fernandez-Vizarra P, 2004, Histol Histopathol, 19, 823
- Zhu X, 2013, J Alzheimers Dis, 33, S253
- Askanas V, 1992, Am J Pathol, 141, 31
- 10.1002/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7 · doi:10.1002/1531-8249(200008)48:2<148::aid-ana3>3.0.co;2-7
- Parker WD, 1990, Proceedings of the 1989 Scientific Meeting of the American Society for Neurological Investigation: New Developments in Neuromuscular Disease
Cited by
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274
Ferroptosis and Cancer: Mitochondria Meet the “Iron Maiden” Cell Death
Battaglia, A. M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., & Biamonte, F. (2020) · Cells · doi:10.3390/cells9061505 · Cited by 561
Gut microbiota and dysbiosis in Alzheimer's disease: Implications for pathogenesis and treatment
Liu, S., Gao, J., Zhu, M., Liu, K., & Zhang, H.-L. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02073-3 · Cited by 516
“Extensive research argues mitochondrial dysfunction [13], insulin resistance (IR) [14], and cerebral hypoperfusion [15] may mediate, drive, or possibly even initiate pathologic molecular cascades in AD and finally promote Aβ accumulation, tau hyperphosphorylation, synaptic degeneration, and neuronal dysfunction.”
BackgroundMitochondrial Oxidative Stress—A Causative Factor and Therapeutic Target in Many Diseases
Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-Ośko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., & Kaczyńska, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413384 · Cited by 495
“Oxidative damage and neuroinflammation have been shown to correlate with Alzheimer’s disease progression [41,44].”
BackgroundAmyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
Reddy, P. H., & Oliver, D. M. (2019) · Cells · doi:10.3390/cells8050488 · Cited by 496
“, Huntington’s disease [39], amyotrophic lateral sclerosis [40], Parkinson’s disease [41], Friedreich ataxia [42], Alzheimer’s disease [43]), and chronic liver diseases (e.”
Background
Metadata
- Authors
- Swerdlow, R. H.
- Affiliations
- University of Kansas (US)
- Corresponding author
- Swerdlow, Russell H.
- ORCID
- Swerdlow, Russell H.
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2017-10-07
- Volume
- 62
- Issue
- 3
- Pages
- 1403-1416
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC5869994
- OpenAlex
- W2764071986
- Cited by
- 850
- References
- 154
- Citations by year
- 2026: 126 · 2025: 106 · 2024: 97 · 2023: 110 · 2022: 122 · 2021: 114 · 2020: 106 · 2019: 49 · 2018: 18 · 2017: 1
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG035982)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, mitochondrial dysfunction
- MeSH terms
- Alzheimer Disease, Animals, Humans, Mitochondria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.